Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Psychopharmacology

• Publication date

  1995-09-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1007/BF02245597PMID 8539335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test

  2005influential reference
• A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.

  1995cited by this paper
• High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group.

  1994cited by this paper
• Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding.

  1994cited by this paper
• An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.

  1994cited by this paper
• Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?

  1994cited by this paper
• The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.

  1993cited by this paper
• Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.

  1993cited by this paper
• Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys.

  1991cited by this paper
• The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist

  1991cited by this paper
• 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

  1991influential reference
• Anxiolytic effects of CCK-B antagonists.

  1991cited by this paper
• Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

  1991cited by this paper
• Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

  1990cited by this paper
• Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic Disorder *

  1990cited by this paper
• The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor

  1990cited by this paper
• Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

  1989cited by this paper
• Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

  1989cited by this paper
• Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

  1989cited by this paper
• Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

  1986cited by this paper
• Behavioral and neurochemical studies on the anticonflict actions of buspirone

  1984cited by this paper
• Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system

  1982cited by this paper
• Conditioned suppression as a monitor of fear of the CS in the course of avoidance training.

  1963cited by this paper

• Stress-induced GHS-R1a expression in medial prefrontal cortical neurons promotes vulnerability to anxiety in mice

  2025cites this paper
• Differential effects of cholecystokinin (CCK‐8) microinjection into the ventrolateral and dorsolateral periaqueductal gray on anxiety models in Wistar rats

  2018cites this paper
• Differential effects of MPEP and diazepam in tests of conditioned emotional response and Pavlovian-to-instrumental transfer suggests ‘anxiolytic’ effects are mediated by different mechanisms

  2009cites this paper
• Functional Interactions between Endocannabinoid and CCK Neurotransmitter Systems May Be Critical for Extinction Learning

  2009cites this paper
• Chapter 4.5 The endocannabinoid system and anxiety responses

  2008cites this paper
• CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

  2006cites this paper
• 24 Cholecystokinin Peptides in Brain Function

  2006cites this paper
• Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light–dark exploration, but not in fear conditioning test

  2005cites this paper
• Social defeat increases alcohol preference of C57BL/10 strain mice; effect prevented by a CCKB antagonist

  2005cites this paper
• Cholecystokinin2 receptor deficient mice: changes in function of GABA-ergic system

  2005cites this paper
• Cholecystokinin and panic disorder

  2004cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice

  2003cites this paper
• Validation of a behavioral recording automated system in the elevated plus-maze test.

  2002cites this paper
• The experimental pharmacotherapy of benzodiazepine withdrawal.

  2002cites this paper
• Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze.

  2002cites this paper
• Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic.

  2001cites this paper
• CCK-B antagonists in the control of anxiety and gastric acid secretion.

  2000cites this paper
• CCK‐antagonists in a rat exposed to acute stress: Implication for anxiety associated with post‐traumatic stress disorder

  1999cites this paper
• Acute and Chronic Citalopram Treatment Differently Modulates Rat Exploratory Behavior in the Exploration Box Test: No Evidence for Increased Anxiety or Changes in the [3H]Raclopride Binding

  1999cites this paper
• Treatment with the Noradrenergic Alpha-2 Agonist Clonidine, But Not Diazepam, Improves Spatial Working Memory in Normal Young Rhesus Monkeys

  1999cites this paper
• Low alcohol preference among the ”high alcohol preference” C57 strain of mice; preference increased by saline injections

  1999cites this paper
• Concurrent chronic administration of a CCKB antagonist can decrease tolerance to the ataxic effects of ethanol

  1999cites this paper
• Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.

  1999cites this paper
• CCK in anxiety and cognitive processes.

  1998cites this paper
• Involvement of GABA(A)-benzodiazepine receptor in the anxiolytic effect induced by hexanic fraction of Rubus brasiliensis.

  1998cites this paper
• CCK receptor antagonists.

  1998cites this paper
• Cholecystokinin as a target for neuropsychiatric drugs.

  1998cites this paper
• CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.

  1998cites this paper
• CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.

  1998cites this paper
• CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours

  1997cites this paper
• The effect of drugs acting on CCK receptors and rat free exploration in the exploration box.

  1997cites this paper
• Cholecystokinin and Psychiatric Disorders

  1997cites this paper
• The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.

  1997cites this paper
• Cholecystokinin in anxiety.

  1996cites this paper
• Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.

  1996cites this paper
• Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide.

  1996cites this paper
• The CCK‐B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle

  1996cites this paper
• Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice

  1996cites this paper